SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Phage Therapeutics International Inc – ‘10SB12G/A’ on 12/5/01 – EX-10.33

On:  Wednesday, 12/5/01   ·   Accession #:  912057-1-542027   ·   File #:  0-31961

Previous ‘10SB12G’:  ‘10SB12G/A’ on 6/6/01   ·   Latest ‘10SB12G’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/05/01  Phage Therapeutics Int’l Inc      10SB12G/A             24:1.4M                                   Merrill Corp/FA

Amendment to Registration of Securities of a Small-Business Issuer   —   Form 10-SB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10SB12G/A   Amendment to Registration of Securities of a        HTML    725K 
                          Small-Business Issuer                                  
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     19K 
 3: EX-10.1     Material Contract                                   HTML     34K 
11: EX-10.10    Material Contract                                   HTML     79K 
12: EX-10.11    Material Contract                                   HTML     78K 
13: EX-10.12    Material Contract                                   HTML     53K 
14: EX-10.13    Material Contract                                   HTML     79K 
15: EX-10.14    Material Contract                                   HTML     22K 
16: EX-10.15    Material Contract                                   HTML     25K 
 4: EX-10.2     Material Contract                                   HTML     30K 
17: EX-10.22    Material Contract                                   HTML     38K 
18: EX-10.23    Material Contract                                   HTML     43K 
19: EX-10.24    Material Contract                                   HTML     43K 
20: EX-10.28    Material Contract                                   HTML     44K 
21: EX-10.29    Material Contract                                   HTML     64K 
 5: EX-10.3     Material Contract                                   HTML     42K 
22: EX-10.30    Material Contract                                   HTML     18K 
23: EX-10.33    Material Contract                                   HTML     46K 
 6: EX-10.4     Material Contract                                   HTML     80K 
 7: EX-10.5     Material Contract                                   HTML     22K 
 8: EX-10.6     Material Contract                                   HTML     18K 
 9: EX-10.8     Material Contract                                   HTML     19K 
10: EX-10.9     Material Contract                                   HTML     23K 
24: EX-21       Subsidiaries of the Registrant                      HTML      9K 


EX-10.33   —   Material Contract
Exhibit Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Master Agreement
"QuickLinks

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Prepared by MERRILL CORPORATION  

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 10.33


MASTER AGREEMENT

RELATING TO:
CONTRACT SERVICES FOR BACTERIOPHAGE PRODUCT

BETWEEN

Phage Therapeutics International Inc.
19211-64th Place NE
Kenmore, WA
98028-3380 USA

and

INTELLIgene Expressions, Inc.
Edmonton Research Park
1938 - 94 Street
Edmonton, Alberta
T6N 1J3
Canada


MASTER AGREEMENT
Contract Services for Bacteriophage Product
CONTENTS


1.

 

Definitions of General Terms

2.

 

Work Orders

3.

 

Conduct of Project Services

4.

 

Supply of Material and Process Information by PTXX

5.

 

Representation and Warranties

6.

 

Indemnification

7.

 

Compensation

8.

 

No Warranty of Merchantability or Fitness

9.

 

Shipment of Samples or Product

10.

 

Confidentiality

11.

 

New Intellectual Property

12.

 

Publicity

13.

 

Liability

14.

 

Term and Termination

15.

 

Force Majeure

16.

 

Independent Contractors

17.

 

Ownership of Assets and Equipment

18.

 

Dispute Resolution

19.

 

Waiver

20.

 

Entirety

21.

 

Notices

Appendix A: Format of Standard Work Order

AGREEMENT

THIS MASTER AGREEMENT ("Agreement") is made effective as of Monday September 11, 2000 ("Effective Date") by and between INTELLIgene Expressions Inc. ("INTELLIgene"), a corporation incorporated under the laws of the province of Alberta, with principal offices at Edmonton Research Park, 1938 - 94 Street, Edmonton, Alberta, Canada T6N 1 J3 and Phage Therapeutics International Inc. ("PTXX"), a corporation incorporated under the laws of the State of Florida, USA with offices at 19211-64th Place NE, Kenmore, WA 98028-3380 USA.

WHEREAS, PTXX and INTELLIgene are desirous of establishing development, scale-up, and GMP manufacturing activities relating to PTXX's bacteriophage product (a.k.a. "Active Pharmaceutical Ingredient"; "API").

NOW, THEREFORE, in consideration of the mutual covenants set forth in this Agreement, PTXX and INTELLIgene hereby agree as follows:

1.  Definitions of General Terms

2.  Work Orders


3.  Conduct of Project Services

4.  Supply of Material and Process Information by PTXX

2


5.  Representation and Warranties

6.  Indemnification

7.  Compensation

3


8.  No Warranty of Merchantability or Fitness

9.  Shipment of Samples or Product

10.  Confidentiality


4


11.  New Intellectual Property

12.  Publicity

13.  Liability

5


14.  Term and Termination


6


15.  Force Majeure

16.  Independent Contractors

17.  Ownership of Assets and Equipment

18.  Dispute Resolution

19.  Waiver

20.  Entirety

7


21.  Notices


If to INTELLIgene
Attn:   Dr. Fahar Merchant, President
Edmonton Research Park
1938 - 94 St
Edmonton, Alberta, Canada T6N 1J3
Fax #: (780) 430-1529

If to PTXX
Attn:   Dr. Richard Honour, President
19211-64th Place NE
Kenmore, WA
98028-3380 USA
Fax #: (425) 482-0834



 

 
INTELLIgene EXPRESSIONS INC.   Phage Therapeutics International, Inc.

/s/ 
FAHAR MERCHANT   
Dr. Fahar Merchant
President
Dated: Friday, September 08, 2000

 

/s/ 
RICHARD C. HONOUR   
Dr. Richard Honour
President
Dated: Monday, September 11, 2000



 

Per:

Name: Richard C. Honour
Title: Director
Dated: 09.11.00

8




QuickLinks

MASTER AGREEMENT

Dates Referenced Herein

This ‘10SB12G/A’ Filing    Date    Other Filings
Filed on:12/5/01None on these Dates
9/11/00
9/8/00
 List all Filings 
Top
Filing Submission 0000912057-01-542027   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 4:36:09.1am ET